tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tyra Biosciences reports Q3 EPS (50c), consensus (51c)
PremiumThe FlyTyra Biosciences reports Q3 EPS (50c), consensus (51c)
2M ago
Tyra Biosciences price target raised to $36 from $30 at Oppenheimer
Premium
The Fly
Tyra Biosciences price target raised to $36 from $30 at Oppenheimer
3M ago
Tyra Biosciences management to meet with Oppenheimer
Premium
The Fly
Tyra Biosciences management to meet with Oppenheimer
4M ago
Tyra Bioscience: Strategic Advancements and Financial Stability Justify Buy Rating
PremiumRatingsTyra Bioscience: Strategic Advancements and Financial Stability Justify Buy Rating
4M ago
Tyra Bioscience: Promising Clinical Trials and Financial Stability Justify Buy Rating
Premium
Ratings
Tyra Bioscience: Promising Clinical Trials and Financial Stability Justify Buy Rating
4M ago
Tyra Biosciences Advances Clinical Programs with Strong Financial Backing
Premium
Company Announcements
Tyra Biosciences Advances Clinical Programs with Strong Financial Backing
4M ago
Tyra Biosciences says first patient dosed in Phase 2 study of TYRA-300
PremiumThe FlyTyra Biosciences says first patient dosed in Phase 2 study of TYRA-300
6M ago
Tyra Biosciences up 3% as RA Capital increases stake to 22.4%
Premium
The Fly
Tyra Biosciences up 3% as RA Capital increases stake to 22.4%
6M ago
Tyra Bioscience Holds 2025 Annual Stockholders Meeting
Premium
Company Announcements
Tyra Bioscience Holds 2025 Annual Stockholders Meeting
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100